Complete response of recurrent malignant struma ovarii followed by ¹³¹I therapy

Junhua Tanga Department of Gynaecology and Obstetrics, Beijing Daxing Maternal and Child Care Hospital, Beijing, China

Pan Haob Department of Nuclear Medicine, Beijing Luhe Hospital, Capital Medical University, Beijing, China

Wei Zhuc Department of Gynaecology and Obstetrics, Jiangxi Fuzhou Chongren General Hospital, Fuzhou, China

Jun Hud Department of Gynaecology and Obstetrics, Perking University First Hospital, Beijing, China

Hongwu Wend Department of Gynaecology and Obstetrics, Perking University First Hospital, Beijing, ChinaCorrespondence[email protected]

References

Boyd JC, Williams BA, Rigby MH, Kieser K, Offman S, Shirsat H, et al. 2017. Malignant struma ovarii in a 30-year old nulliparous patient. Thyroid Research 10:3.
PubMed Web of Science ®Google Scholar
Goffredo P, Sawka AM, Pura J, Adam MA, Roman SA, Sosa JA. 2015. Malignant struma ovarii: a population-level analysis of a large series of 68 patients. Thyroid: Official Journal of the American Thyroid Association 25:211–215.
PubMed Web of Science ®Google Scholar
Jean S, Tanyi JL, Montone K, McGrath C, Lage-Alvarez MM, Chu CS. 2012. Papillary thyroid cancer arising in struma ovarii. Journal of Obstetrics and Gynaecology 32:222–226.
Web of Science ®Google Scholar
Robboy SJ, Shaco-Levy R, Peng RY, Snyder MJ, Donahue J, Bentley RC, et al. 2009. Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. International Journal of Gynecological Pathology28:405–422.
PubMed Web of Science ®Google Scholar
Shrimali RK, Shaikh G, Reed NS. 2012. Malignant struma ovarii: the west of Scotland experience and review of literature with focus on postoperative management. Journal of Medical Imaging and Radiation Oncology 56:478–482.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Complete response of recurrent malignant struma ovarii followed by ¹³¹I therapy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Complete response of recurrent malignant struma ovarii followed by 131I therapy

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Complete response of recurrent malignant struma ovarii followed by ¹³¹I therapy